Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.51 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | AURKA | O14965 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1784909 | 1.00 | CHRNB2 (0.51) | CHRNB2CHRNA4MEN1CYP2D6CYP2C19 | |
| SCHEMBL31287191 | 1.00 | CHRNB2 (0.51) | CHRNB2CHRNA4MEN1CYP2D6CYP2C19 | |
| SCHEMBL3163175 | 1.00 | CHRNB2 (0.51) | CHRNB2CHRNA4MEN1CYP2D6CYP2C19 | |
| SCHEMBL3536308 | 1.00 | CHRNB2 (0.51) | CHRNB2CHRNA4MEN1CYP2D6CYP2C19 | |
| SCHEMBL19855209 | 0.98 | CHRNB2 (0.50) | CHRNB2CHRNA4MEN1CYP2D6CYP2C19 | |
| SCHEMBL21167132 | 0.98 | CHRNB2 (0.50) | CHRNB2CHRNA4MEN1CYP2D6CYP2C19 | |
| SCHEMBL3163066 | 0.98 | CHRNB2 (0.50) | CHRNB2CHRNA4MEN1CYP2D6CYP2C19 | |
| SCHEMBL3926825 | 0.95 | CHRNB2 (0.50) | CHRNB2CHRNA4MEN1CYP2D6CYP2C19 | |
| SCHEMBL29977611 | 0.95 | CHRNB2 (0.50) | CHRNB2CHRNA4MEN1CYP2D6CYP2C19 | |
| SCHEMBL20707 | 0.95 | CHRNB2 (0.50) | CHRNB2CHRNA4MEN1CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121208173-A | Application of (R) -2- (2-piperidyl) pyridine as internal standard in detection of pseudoscouring in main stream smoke of cigarettes and detection method of pseudoscouring in detection of anabasine gas chromatography mass spectrum | 中国烟草总公司郑州烟草研究院 | 2025-12-26 | — | — | CN | disclosed |
| CN-121208173-A | Application of (R) -2- (2-piperidyl) pyridine as internal standard in detection of pseudoscouring in main stream smoke of cigarettes and detection method of pseudoscouring in detection of anabasine gas chromatography mass spectrum | 中国烟草总公司郑州烟草研究院 | 2025-12-26 | — | — | CN | disclosed |
| EP-3924349-B1 | AMINO ACID DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | THE ROSKAMP INST (US) | 2025-06-25 | — | — | EP | disclosed |
| US-20220081415-A1 | Amino Acid Derivatives for the Treatment of Inflammatory Diseases | THE ROSKAMP INST (US) | 2022-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220081415-A1 | Amino Acid Derivatives for the Treatment of Inflammatory Diseases | NFKBIA, NFRKB, IKBKG | CHRNB2 4055/4885CHRNA4 4587/4885MEN1 4711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.